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Background: The rapidly expanding technique of wave intensity analysis (WIA) requires that coronary wave speed is known. This study is the first 
to directly measure coronary wave speed in humans and compare it to the single-point technique (SPc), which is derived from local pressure and 
velocity signals, but has not been validated in coronary vessels.
methods: In 11 patients undergoing cardiac catheterization, intracoronary pressure was measured in angiographically normal epicardial coronary 
arteries using a high-fidelity catheter equipped with two pressure sensors located Δs = 5 cm apart. The actual wave speed was calculated as c=Δs/
Δt, where Δt is the time delay between the two pressure signals. Simultaneously, intracoronary pressure (P) and flow velocity (U) were measured 
with a dual-sensor guide wire to derive SPc = 1/ρ ∙ √(∑dP2 / ∑dU2), where ρ is the blood density. All signals were recorded at baseline, at maximal 
hyperemia induced by intracoronary adenosine, and after large vessel relaxation by nitroglycerin (NTG) injection at rest and hyperemia. Changes in 
the energy of the early diastolic backward expansion wave (BEW) were assessed at maximal hyperemia using SPc and c.
results: At baseline, c = 16.6 ± 6.6 m/s equaled SPc = 18.7 ± 5.8 m/s (p>0.05). During hyperemia, SPc dropped by 39% to 11.4 ± 3.7 m/s 
(p<0.001), while c increased by 9% to 18.3 ± 8.2 m/s (p<0.05). NTG administration did not affect c or SPc. Small vessel dilation after NTG did 
not change c, but again lowered SPc to 12.5 ± 5.3 m/s (p<0.05). This change in SPc was strongly related to the baseline value (r=0.89) and 
proportionally affected the BEW, which overall decreased by 10%. Notably, SPc at baseline did not differ from c during hyperemia (p>0.05).
conclusion: In agreement with animal data, coronary wave speed in humans remains essentially constant after microvascular dilatation. While the 
SPc reliably appraises wave speed in normal vessels under resting conditions, it markedly underestimates true wave speed during hyperemia, leading 
to a progressive underestimation of the BEW. However, our results suggest that SPc assessed at baseline can be used for WIA during hyperemia, 
which greatly extends its validity to study coronary physiology.
